<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Monopar Therapeutics (MNPR) on GreekSoup</title>
<link>https://greeksoup.ai/stocks/us/mnpr/</link>
<description>Every dated entry in the public record on Monopar Therapeutics: results, filings, insider trades and the rest, from the filings, the last 90 days.</description>
<language>en</language>
<atom:link href="https://greeksoup.ai/stocks/us/mnpr/feed.xml" rel="self" type="application/rss+xml"/>
<lastBuildDate>Fri, 30 Oct 2026 00:00:00 +0000</lastBuildDate>
<item><title>Monopar Therapeutics: Schedule 13G filed by BlackRock, Inc., 5.0% of the class</title><link>https://greeksoup.ai/stocks/us/mnpr/holders/</link><guid isPermaLink="false">us:MNPR:schedule-13:2026-10-27:1cf82f6930</guid><pubDate>Tue, 27 Oct 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000201238326003819/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/holders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: short interest 1,128,617 shares at the 15 October 2026 settlement, 7.14 days to cover</title><link>https://greeksoup.ai/stocks/us/mnpr/short-interest/</link><guid isPermaLink="false">us:MNPR:short-interest:2026-10-15:e539e85638</guid><pubDate>Thu, 15 Oct 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Starr Christopher M (Director) sold 4,631 shares (under a trading plan set in advance) at $78.09 on 1 October 2026, $361,635</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-10-05:52bb46a5a4</guid><pubDate>Mon, 05 Oct 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926032048/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Starr Christopher M (Director) sold 2,970 shares (under a trading plan set in advance) at $78.82 on 1 October 2026, $234,095</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-10-05:6250353ff3</guid><pubDate>Mon, 05 Oct 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926032048/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Starr Christopher M (Director) sold 799 shares (under a trading plan set in advance) at $79.67 on 1 October 2026, $63,656</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-10-05:1390ace0e3</guid><pubDate>Mon, 05 Oct 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926032048/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Form 144, CHRISTOPHER STARR plans to sell 16,800 shares worth $1.3 million around 1 October 2026</title><link>https://greeksoup.ai/stocks/us/mnpr/planned-sales/</link><guid isPermaLink="false">us:MNPR:planned-sale:2026-10-01:856015de82</guid><pubDate>Thu, 01 Oct 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000195004726009981/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: short interest 1,086,279 shares at the 30 September 2026 settlement, 6.02 days to cover</title><link>https://greeksoup.ai/stocks/us/mnpr/short-interest/</link><guid isPermaLink="false">us:MNPR:short-interest:2026-09-30:919919d713</guid><pubDate>Wed, 30 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Robinson Chandler (Chief Executive Officer) sold 10,450 shares (under a trading plan set in advance) at $87.15 on 24 September 2026, $910,718</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-09-28:d0fe0d5075</guid><pubDate>Mon, 28 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926031411/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Robinson Chandler (Chief Executive Officer) sold 9,638 shares (under a trading plan set in advance) at $87.96 on 24 September 2026, $847,758</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-09-28:2290f11462</guid><pubDate>Mon, 28 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926031411/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Robinson Chandler (Chief Executive Officer) sold 8,368 shares (under a trading plan set in advance) at $88.97 on 24 September 2026, $744,501</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-09-28:7ceeaa876b</guid><pubDate>Mon, 28 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926031411/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Robinson Chandler (Chief Executive Officer) sold 600 shares (under a trading plan set in advance) at $89.79 on 24 September 2026, $53,874</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-09-28:ec042a1d7f</guid><pubDate>Mon, 28 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926031411/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Form 144, CHANDLER ROBINSON plans to sell 29,056 shares worth $2.6 million around 24 September 2026</title><link>https://greeksoup.ai/stocks/us/mnpr/planned-sales/</link><guid isPermaLink="false">us:MNPR:planned-sale:2026-09-24:c0f025679c</guid><pubDate>Thu, 24 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000195004726009797/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: short interest 844,226 shares at the 15 September 2026 settlement, 7.20 days to cover</title><link>https://greeksoup.ai/stocks/us/mnpr/short-interest/</link><guid isPermaLink="false">us:MNPR:short-interest:2026-09-15:54940ae933</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: short interest 852,425 shares at the 31 August 2026 settlement, 4.54 days to cover</title><link>https://greeksoup.ai/stocks/us/mnpr/short-interest/</link><guid isPermaLink="false">us:MNPR:short-interest:2026-08-31:c8613555bb</guid><pubDate>Mon, 31 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Rioux Patrice (Insider) sold 1 shares (under a trading plan set in advance) at $111.26 on 26 August 2026, $111</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-08-27:646eab46c9</guid><pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926029121/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Tsuchimoto Kim R (Director) sold 485 shares (under a trading plan set in advance) at $108.83 on 26 August 2026, $52,783</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-08-27:d8e16255de</guid><pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926029116/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Tsuchimoto Kim R (Director) sold 615 shares (under a trading plan set in advance) at $109.56 on 26 August 2026, $67,379</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-08-27:bcc0c6cfd0</guid><pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926029116/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Tsuchimoto Kim R (Director) sold 700 shares (under a trading plan set in advance) at $110.65 on 26 August 2026, $77,455</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-08-27:4aea27a4e3</guid><pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926029116/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Tsuchimoto Kim R (Director) sold 1,098 shares (under a trading plan set in advance) at $111.84 on 26 August 2026, $122,800</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-08-27:df01082520</guid><pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926029116/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Tsuchimoto Kim R (Director) sold 602 shares (under a trading plan set in advance) at $112.93 on 26 August 2026, $67,984</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-08-27:85d8591ace</guid><pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926029116/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Tsuchimoto Kim R (Director) sold 590 shares (under a trading plan set in advance) at $113.84 on 26 August 2026, $67,166</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-08-27:21488432f8</guid><pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926029116/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Anderson Raymond (Director) sold 694 shares (under a trading plan set in advance) at $110.04 on 25 August 2026, $76,368</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-08-27:8c5b58b035</guid><pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926029115/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Anderson Raymond (Director) sold 646 shares (under a trading plan set in advance) at $110.07 on 25 August 2026, $71,105</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-08-27:af7ccb5357</guid><pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926029115/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Anderson Raymond (Director) sold 1,802 shares (under a trading plan set in advance) at $113.05 on 25 August 2026, $203,716</title><link>https://greeksoup.ai/stocks/us/mnpr/insiders/</link><guid isPermaLink="false">us:MNPR:insider:2026-08-27:7eaaa0d6dd</guid><pubDate>Thu, 27 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926029115/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Form 144, PATRICE RIOUX plans to sell 1 shares worth $111 around 26 August 2026</title><link>https://greeksoup.ai/stocks/us/mnpr/planned-sales/</link><guid isPermaLink="false">us:MNPR:planned-sale:2026-08-26:0a4b952682</guid><pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000195004726008724/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Form 144, KIM TSUCHIMOTO plans to sell 8,180 shares worth $906,508 around 26 August 2026</title><link>https://greeksoup.ai/stocks/us/mnpr/planned-sales/</link><guid isPermaLink="false">us:MNPR:planned-sale:2026-08-26:310c430c2c</guid><pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000195004726008721/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Form 144, RAYMOND WILLIAM ANDERSON plans to sell 6,284 shares worth $699,786 around 25 August 2026</title><link>https://greeksoup.ai/stocks/us/mnpr/planned-sales/</link><guid isPermaLink="false">us:MNPR:planned-sale:2026-08-25:8febbe74f6</guid><pubDate>Tue, 25 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000195004726008691/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: short interest 887,188 shares at the 14 August 2026 settlement, 3.48 days to cover</title><link>https://greeksoup.ai/stocks/us/mnpr/short-interest/</link><guid isPermaLink="false">us:MNPR:short-interest:2026-08-14:f49003aebe</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics Q2 FY2026 results: revenue $0, net income -$5 million</title><link>https://greeksoup.ai/stocks/us/mnpr/results/fy2026-q2/</link><guid isPermaLink="false">us:MNPR:result:2026-08-12:3bbc72d7f8</guid><pubDate>Wed, 12 Aug 2026 00:00:00 +0000</pubDate><category>Results</category><description><![CDATA[<p>Results. <a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001645469&amp;type=10-&amp;dateb=&amp;owner=include&amp;count=40">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/results/fy2026-q2/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics filed 8-K: results of operations</title><link>https://greeksoup.ai/stocks/us/mnpr/filings/</link><guid isPermaLink="false">us:MNPR:filing:2026-08-12:8601128d24</guid><pubDate>Wed, 12 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926027165/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics filed 10-Q: form 10-q</title><link>https://greeksoup.ai/stocks/us/mnpr/filings/</link><guid isPermaLink="false">us:MNPR:filing:2026-08-12:aa12ddf6c6</guid><pubDate>Wed, 12 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000143774926027164/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Schedule 13G/A filed by Saturn V Capital Management LP, 4.7% of the class</title><link>https://greeksoup.ai/stocks/us/mnpr/holders/</link><guid isPermaLink="false">us:MNPR:schedule-13:2026-08-12:16d6b46d5d</guid><pubDate>Wed, 12 Aug 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000206075726000047/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/holders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Monopar Therapeutics: Schedule 13G/A filed by Adage Capital Management, L.P., 4.8% of the class</title><link>https://greeksoup.ai/stocks/us/mnpr/holders/</link><guid isPermaLink="false">us:MNPR:schedule-13:2026-08-12:66d88b4b8b</guid><pubDate>Wed, 12 Aug 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/1645469/000091957426004969/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/mnpr/holders/">The page on GreekSoup</a>.</p>]]></description></item>
</channel>
</rss>
